Cardiol Therapeutics Financial Overview
Cardiol Therapeutics's market cap is currently $102.92M. The company's EPS TTM is $-0.08697852; its P/E ratio is -3.37; Cardiol Therapeutics is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
